Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
Asia-Pacific Journal of Clinical Oncology|December 21, 2022
Serum miR-146a level is a potential biomarker in predicting the outcome of diffuse large B-cell lymphomaXin Huang, Ailing Gui, Yi Zhou, et al.International Journal of Molecular Sciences|December 11, 2022
A Regulatory Loop Involving miR-200c and NF-κB Modulates Mortalin Expression and Increases Cisplatin Sensitivity in an Ovarian Cancer Cell Line ModelXin Huang, Yichen Yan, Ailing Gui, et al.Frontiers in Oncology|May 4, 2026
Elevated FGR protein expression identifies a high-risk subset of diffuse large B-cell lymphoma and a potential therapeutic targetKexin Shen, Shiyu Jiang, Ailing Gui, et al.Journal of Cancer|February 14, 2022
Deubiquitinase OTUD7B is a potential prognostic biomarker in diffuse large B-cell lymphomaShi Qiu, Yizhen Liu, Ailing Gui, et al.Annals of Translational Medicine|June 20, 2022
Mitochondria-specific peptide amphiphiles induce mitochondrial dysfunction and peripheral T-cell lymphomas (PTCL) damageQi Sun, Ailing Gui, Aihua Zou, et al.Brain and Behavior|March 2, 2023
Contactin-6-deficient male mice exhibit the abnormal function of the accessory olfactory system and impaired reproductive behaviorWei Zhang, Huiling Huang, Ailing Gui, et al.Asia-Pacific Journal of Clinical Oncology|November 24, 2025
Prognostic Significance of Deubiquitinase OTUD7B in NK/T-Cell LymphomaYizhen Liu, Shujuan Wen, Zuguang Xia, et al.Neuroscience Bulletin|June 13, 2026
CNTN6 Modulates Slit-Robo Signaling in Cortical GABAergic Interneuron MigrationYiliang Xu, Tian Zhao, Dan Zhao, et al.International Journal of Hematology|May 10, 2022
Hexokinase II expression as a prognostic marker in diffuse large B-cell lymphoma: pre- and post-rituximab eraJia Jin, Ailing Gui, Guangliang Chen, et al.Annals of Hematology|May 18, 2026
Zanubrutinib potentiates polatuzumab vedotin efficacy in DLBCL with concurrent CD79b upregulationXiaolong Zhou, Jingjing Li, Zipeng Zhao, et al.Pageof 2